These results reveal a mechanism for the regulation of Pgrn levels in the brain and provide insight into the pathophysiology of several neurodegenerative diseases associated with PGRN expression levels, such as AD, FTLD, and NCL. The gene discussed is GRN; the disease is Alzheimer disease.